Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Current Considerations in Heavy Charged-Particle Radiotherapy: A Clinical Research Trial of the University of California Lawrence Berkeley Laboratory, Northern California Oncology Group, and Radiation Therapy Oncology Group

J. R. Castro, G. T. Y. Chen and E. A. Blakely
Radiation Research Supplement
Vol. 8, Heavy Charged Particles in Research and Medicine. Proceedings of a Symposium Held at the Lawrence Berkeley Laboratory, University of California, Berkeley, California, May 1-3, 1985 (Nov., 1985), pp. S263-S271
DOI: 10.2307/3583536
Stable URL: http://www.jstor.org/stable/3583536
Page Count: 9
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Current Considerations in Heavy Charged-Particle Radiotherapy: A Clinical Research Trial of the University of California Lawrence Berkeley Laboratory, Northern California Oncology Group, and Radiation Therapy Oncology Group
Preview not available

Abstract

Phase I and II radiotherapy trials with accelerated high-energy heavy charged-particle beams have been carried out at the University of California Lawrence Berkeley Laboratory in conjunction with the Northern California Oncology Group and the Radiation Therapy Oncology Group. Clinical experience with several anatomical regions and tumor types has been accumulated. Preliminary observations suggest that toxicity is acceptable with treatment techniques developed for neon ions. Further data must be accumulated for carbon or silicon ion therapy. Initial Phase III trials with neon ions should begin shortly; evaluation of optimal ions and techniques for improved dose localization is ongoing. Future directions for optimization of heavy charged-particle radiotherapy are presented.

Page Thumbnails

  • Thumbnail: Page 
S263
    S263
  • Thumbnail: Page 
S264
    S264
  • Thumbnail: Page 
S265
    S265
  • Thumbnail: Page 
S266
    S266
  • Thumbnail: Page 
S267
    S267
  • Thumbnail: Page 
S268
    S268
  • Thumbnail: Page 
S269
    S269
  • Thumbnail: Page 
S270
    S270
  • Thumbnail: Page 
S271
    S271